References
- Pignon JP, Bourhis J, Domenge C, Designe L. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data MACH-NC Collaborative Group. Meta-Analysis of chemotherapy on head and neck cancer. Lancet 2000;355:949–55.
- Scully C, Bagan J. Oral squamous cell carcinoma: overview of current understanding of aetiopathogenesis and clinical implications. Oral Dis 2009;15:388–99.
- Garavello W, Ciardo A, Spreafico R, Gaini RM. Risk factors for distant metastases in head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 2006;132:762–6.
- Reuter CW, Morgan MA, Eckardt A. Targeting EGF-receptor signalling in squamous cell carcinomas of the head and neck. Br J Cancer 2007;96:408–16.
- Newman DJ, Cragg GM. Natural products as sources of new drugs over the last 25 years. J Nat Prod 2007;70:461–77.
- Aggarwal BB, Takada Y, Oommen OV. From chemoprevention to chemotherapy: common targets and common goals. Expert Opin Investig Drugs 2004;13:1327–38.
- Strimpakos AS, Sharma RA. Curcumin: preventive and therapeutic properties in laboratory studies and clinical trials. Antioxid Redox Signal 2008;10:511–45.
- Newman DJ, Cragg GM, Snader KM. Natural products as sources of new drugs over the period 1981–2002. J Nat Prod 2003;66:1022–37.
- Srinivasan M, Rajendra Prasad N, Menon VP. Protective effect of curcumin on gama-radiation induced DNA damage and lipid peroxidation in cultured lymphocytes. Mutat Res 2006;611:96–103.
- Aggarwal S, Takada Y, Singh S, Myers JN, Aggarwal BB. Inhibition of growth and survival of human head and neck squamous cell carcinoma cells by curcumin via modulation of nuclear factor-kappaB signaling. Int J Cancer 2004;111:679–92.
- Rogers SJ, Harrington KJ, Rhys-Evans P, O-Charoenrat P, Eccles SA. Biological signifficance of c-erbB family oncogenes in head and neck cancer. Cancer Metastasis Rev 2005;24:47–69.
- Baselga J, Averbuch SD. ZD1839 (‘Iressa’) as an anticancer agent. Drugs 2000;60:33–40.
- Jagetia GC. Radioprotection and radiosensitization by curcumin. Adv Exp Med Biol 2007;595:301–20.
- Khafif A, Lev-Ari S, Vexler A, Barnea I, Starr A, Karaush V, Curcumin: a potential radio-enhancer in head and neck cancer. Laryngoscope 2009;119:2019–26.
- Moreno-Jiménez M, Valero J, López-Picazo JM, Arbea L, Aristu J, Cambeiro M, Concomitant cisplatin, paclitaxel, and hyperfractionated radiotherapy in locally advanced head and neck cancer: comparison of two different schedules. Am J Clin Oncol 2010;33:137–43.
- Carmichael J, DeGraff WG, Gazdar AF, Minna JD, Mitchell JB. Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. Cancer Res 1987;47:936–42.
- Carmichael J, DeGraff WG, Gazdar AF, Minna JD, Mitchell JB. Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of radiosensitivity. Cancer Res 1987;47:943–6.
- Tanaka T, Makita H, Ohnishi M, Hirose Y, Wang A, Mori H, Chemoprevention of 4-nitroquinoline 1-oxide-induced oral carcinogenesis by dietary curcumin and hesperid comparison with the protective effect of beta-carotene. Cancer Res 1994;54:4653–9.
- Azuine MA, Bhide SV. Adjuvant chemoprevention of experimental cancer: catechin and dietary turmeric in forestomach and oral cancer models. J Ethnopharmacol 1994;44:211–17.
- Chendil D, Ranga RS, Meigooni D, Sathishkumar S, Ahmed MM. Curcumin confers radiosensitizing effect in prostate cancer cell line PC-3. Oncogene 2004;23:1599–607.
- Khafif A, Hurst R, Kyker K, Fliss DM, Gil Z, Medina JE. Curcumin: a new radio-sensitizer of squamous cell carcinomacells. Otolaryngol Head Neck Surg 2005;132:317–21.
- Cheng AL, Hsu CH, Lin JK, Hsu MM, Ho YF, Shen TS, Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Res 2001;21:2895–900.
- Abraham SK, Sarma L, Kesavan PC. Protective effects of chlorogenic acid, curcumin and beta-carotene against gamma-radiation-induced in vivo chromosomal damage. Mutat Res 1993;303:109–12.